{"name":"Pronova BioPharma","slug":"pronova-biopharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Omega-3-acid ethyl esters 90","genericName":"Omega-3-acid ethyl esters 90","slug":"omega-3-acid-ethyl-esters-90","indication":"Hypertriglyceridemia (severe, typically ≥500 mg/dL)","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Statins","genericName":"Statins","slug":"statins","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Omega-3-acid ethyl esters 90","genericName":"Omega-3-acid ethyl esters 90","slug":"omega-3-acid-ethyl-esters-90","phase":"marketed","mechanism":"Omega-3-acid ethyl esters reduce triglyceride levels by decreasing hepatic production of triglyceride-rich lipoproteins and increasing clearance of triglycerides from the bloodstream.","indications":["Hypertriglyceridemia (severe, typically ≥500 mg/dL)","Cardiovascular risk reduction in patients with elevated triglycerides"],"catalyst":""},{"name":"Statins","genericName":"Statins","slug":"statins","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE9nZTE5cFVTVXNXOS1fYkpjTkJPOGdvV1V1bTVwVWpWM2xCQnJMWG14WldJdUhMSUVyWk1UTmVHYzdmdWNNM2gtdllKVktGOGdMd2tscEFGc0ROdExtRG1XcHlOQ3B1TmZhMDhOUE1JY1lIT0x4dFdscw?oc=5","date":"2022-06-24","type":"pipeline","source":"Labiotech.eu","summary":"Why a Big Pharma Background Can Give Biotech Leaders an Edge - Labiotech.eu","headline":"Why a Big Pharma Background Can Give Biotech Leaders an Edge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOejBBNG9lRExxTE9iSWJQQk1FSGxHR094NlpWRm9zTzh5MTdxMjJYRnRQTlk0YVhORjlSMUg1RnNCZjNNbldsdDBscmRQbzVnMVRJUmdtTzlLdXRPTTV0WU5VSDVweEx4cXRoejNWZTJoSDZoWWpEd1Nic3dGVWI3RmRTMDdXdk1DSXVPLXJteldCWVE?oc=5","date":"2017-12-12","type":"trial","source":"Fierce Biotech","summary":"Ex-Dezima executives scoop €25M for midphase NASH trial - Fierce Biotech","headline":"Ex-Dezima executives scoop €25M for midphase NASH trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPbF9MaFJiOGVqZmRXQUdLWHpQWWY5T0RNUkV1alowYjVZVE94eGVFQndVbmxGdTVfRjlNUExhY1g0amI1WTc2emRxcVpwQWVpWjZvV0p6ZXloX21MRnF4YVlBRVF0X2Y1MkZQWXhyUkRWX0lxZ0ttcHM5RmZrZlpULVdBMTBUcUU3a1FsenVXaV82MWlHYVE?oc=5","date":"2017-11-09","type":"trial","source":"IPWatchdog.com","summary":"Avoiding drug development clinical trials from being an invalidating public use - IPWatchdog.com","headline":"Avoiding drug development clinical trials from being an invalidating public use","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPZ1ZrcUlmWVNSNGN3UktsWjh3c2VuWDYydzRCQXRpOUNWUEZzdVNMQzh0dEE5aGpFVUhTcWNPekNPZmh3aVlab1BBd1JuR2NOT21Iand1blRBclp3YWNkc2tLQnpGWDAtZlZfTFB3MlNCMHc3ek9ENFlETEthZ1plUzZpcG9LbG1oVEV2NDl0Y1Y?oc=5","date":"2014-04-09","type":"patent","source":"PMLiVE","summary":"Teva launches first generic of GSK’s Lovaza in US - PMLiVE","headline":"Teva launches first generic of GSK’s Lovaza in US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQVG5IVHdYMTRqam82dkRaZTg3U0poQmtHaF93Mkx0b1I4OS04aWs5SnhBWnRpUV9QMHhPanEyckliWjBLQjVuQk1iSnJoR182dVVKSGwtZ0FCZEltQWtfTjg1cWFva1NfdTJzRjlhSy13UjVrVVdwTjNNaWQwSjhFRFBxWVpucExfWTdrYnpSSHJEQ3g0NmFkMENETGRlWWVYdjZqUTNHRQ?oc=5","date":"2013-01-31","type":"pipeline","source":"European Pharmaceutical Review","summary":"BASF completes acquisition of Pronova BioPharma - European Pharmaceutical Review","headline":"BASF completes acquisition of Pronova BioPharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE8tX0Flcl8xQk9FVkwxMTU5V0ktUDBBaE1XLUFZNzdlU0hfd3lvNVVoLXdpOGo1QmpkS1h0Y21LejRHMUZhbm41cm9VUmRWR25UTWtUcV9XdGk1emszWDdPMF9RUkNLaFJVNDZF?oc=5","date":"2013-01-08","type":"deal","source":"Genetic Engineering and Biotechnology News","summary":"Top 25 M&A Deals of 2012 - Genetic Engineering and Biotechnology News","headline":"Top 25 M&A Deals of 2012","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQbVlmcVpoMTU2Yi15Sm1zSU05SmlmRjJhdXRZUlBnTlMxd0Rxc1J5UkJQcTZJVjFRS3BuZi1HbXctdGJhZllkU1VZNWRNNmZqdUZaTXhMYWppNnppd2MwTU5pMXlqMTFFSlFiV2FQTGVlTldLSHEybEhJMDZGN010RE9DaGFFWFJOUFF6MU5qV1VUYV9JdEQwbnpR?oc=5","date":"2013-01-01","type":"pipeline","source":"Food Ingredients First","summary":"BASF Completes Acquisition of Pronova BioPharma - Food Ingredients First","headline":"BASF Completes Acquisition of Pronova BioPharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNMnBwb1VrTkxnUU02N2V6OURXc3lOT3Y5RjdqUGFuaHlXMTNBMkhuTjZNSlhfcFNDaGpmbnQ0dkZWRV81RFRGVEhMMTU5R2Y1U3BPbGRMLTlSTk42QjVEakY1dWxVUzdYbFQ5d1hpZDJDa0dOX1pCWTNGNy1xeVRoUU1HSHh4S0g5MEwySzdHMWVzLU42SXhKRl9MRWQ?oc=5","date":"2012-10-02","type":"regulatory","source":"Asian Scientist Magazine","summary":"Lotriga 2g Receives NDA Approval In Japan For Hyperlipidemia - Asian Scientist Magazine","headline":"Lotriga 2g Receives NDA Approval In Japan For Hyperlipidemia","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1VZDBLbEVsY1VIcGNCODRwMzF6NEdONktlTkdHcnJ2TnBNdlFSSjJBYzJaaUJaWWs1VzJJTnlNaFRETjBzMWlzY2s0QjBFNi1rbHN3U05RY2tFcXhqZHVCTENFQTVjV1lrVXF3UzVVaXBUOWV5YUIw?oc=5","date":"2012-06-06","type":"pipeline","source":"Nutritional Outlook","summary":"Everywhere Omega Fatty Acids - Nutritional Outlook","headline":"Everywhere Omega Fatty Acids","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE1GaUZzSjlxSGpBUU4tV0ZBdXRXTUI3ZFVXX0M2NUtNclNJbVRlZTJpeGxFMEdXdkRXUTVKV19MTHNIaHpYblk0djZGbUpFSWUyVWpRV0xUd0hyREVXY3BUNEp3TnVMd05ZN0tNZWNwUjNjZVFUak5PYlEyNlAxalU?oc=5","date":"2009-09-29","type":"pipeline","source":"Pharmaceutical Technology","summary":"Pronova Biopharma Pharmaceutical Production Facility - Pharmaceutical Technology","headline":"Pronova Biopharma Pharmaceutical Production Facility","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}